Table 1.
The IgG, IgM, IgA, IgE level in serum of four patients before and 4 days after initial ScIg administration of Subcuvia®
| IgG (mg/dl) | IgA (mg/dl) | IgM (mg/dl) | IgE (kU/l) | Specific antibody | |
|---|---|---|---|---|---|
| Patients (before ScIg) | |||||
| Patient 1 | 58.0 | <5.5 | 34.0 | <0.35 | RF (−) Isohaemagglutinins (−) Coombs tests (−) |
| Patient 2 | 182.0 | <5.5 | 32.2 | <0.35 | |
| Patient 3 | 252.0 | <5.5 | 5.0 | <0.35 | |
| Patient 4 | 269.0 | <5.5 | 61.2 | <0.35 | |
| Median | 217 | <5.5 | 33.1 | <5 | |
| Patients (+4 days after ScIg) Coombs tests (+) | |||||
| Patient 1 | 426.0 | <5.5 | 32.2 | 0.5 | RF-12 |
| Patient 2 | 585.0 | 22.0 | 27.8 | 14.0 | RF-11 |
| Patient 3 | 354.0 | 22.0 | 4.8 | 22.0 | RF-5 |
| Patient 4 | 396.0 | 25.0 | 59.8 | 16.0 | RF-4 |
| Median | 411.0 | 22.0 | 30.0 | 18.0 | RF-8 IU/ml |